Krane Funds Advisors LLC Purchases 1,109 Shares of HUTCHISON CHINA/S (HCM)

Krane Funds Advisors LLC grew its position in shares of HUTCHISON CHINA/S (NASDAQ:HCM) by 6.4% in the 1st quarter, HoldingsChannel reports. The fund owned 18,414 shares of the company’s stock after buying an additional 1,109 shares during the period. Krane Funds Advisors LLC’s holdings in HUTCHISON CHINA/S were worth $563,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCM. Macquarie Group Ltd. purchased a new position in HUTCHISON CHINA/S in the fourth quarter worth $46,000. Quantamental Technologies LLC purchased a new position in HUTCHISON CHINA/S in the fourth quarter worth $48,000. Bank of Montreal Can boosted its position in HUTCHISON CHINA/S by 238.5% in the fourth quarter. Bank of Montreal Can now owns 4,400 shares of the company’s stock worth $102,000 after purchasing an additional 3,100 shares during the last quarter. QS Investors LLC purchased a new position in HUTCHISON CHINA/S in the fourth quarter worth $139,000. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. purchased a new position in HUTCHISON CHINA/S in the fourth quarter worth $154,000. Hedge funds and other institutional investors own 17.92% of the company’s stock.

Shares of NASDAQ HCM opened at $26.52 on Thursday. HUTCHISON CHINA/S has a one year low of $20.83 and a one year high of $39.68. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.19 and a current ratio of 4.33. The firm has a market cap of $3.15 billion, a PE ratio of -46.52 and a beta of 1.04.

Several research firms have weighed in on HCM. BidaskClub cut HUTCHISON CHINA/S from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 25th. Zacks Investment Research raised HUTCHISON CHINA/S from a “sell” rating to a “hold” rating in a research report on Wednesday, April 17th. Finally, HSBC began coverage on HUTCHISON CHINA/S in a research report on Wednesday, March 27th. They issued a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $26.82.

TRADEMARK VIOLATION NOTICE: “Krane Funds Advisors LLC Purchases 1,109 Shares of HUTCHISON CHINA/S (HCM)” was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/05/16/krane-funds-advisors-llc-purchases-1109-shares-of-hutchison-china-s-hcm.html.

HUTCHISON CHINA/S Company Profile

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

Featured Article: Asset Allocation and Your Retirement

Want to see what other hedge funds are holding HCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HUTCHISON CHINA/S (NASDAQ:HCM).

Institutional Ownership by Quarter for HUTCHISON CHINA/S (NASDAQ:HCM)

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.